[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634911":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":31,"centralContacts":35,"locations":44,"responsibleParty":62,"collaborators":27,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":27,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":27,"enrollmentInfo":73,"targetDuration":27,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":27,"overallStatus":83,"whyStopped":27,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Supportive care (HWC)","EXPERIMENTAL","Patients attend an initial HWC session over 60 minutes and then attend follow-up HWC sessions over 20-60 minutes each monthly for up to 5 months.",[13,14,15],"Other: Counseling","Other: Interview","Other: Questionnaire Administration",[17,23,28],{"type":6,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"Counseling","Attend HWC sessions",[9],[22],"Counseling Intervention",{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Interview","Ancillary studies",[9],null,{"type":6,"name":29,"description":25,"armGroupLabels":30,"otherNames":27},"Questionnaire Administration",[9],[32],{"name":33,"affiliation":5,"role":34},"Abd Moain Abu Dabrh, MB, BCh, MS","PRINCIPAL_INVESTIGATOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":27,"email":40},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",{"name":42,"role":38,"phone":43,"phoneExt":27,"email":27},"Megan Warner","904-953-0476",[45],{"facility":46,"status":27,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Mayo Clinic in Florida","Jacksonville","Florida","32224-9980","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-81.65565,30.33218,{"lat":56,"lon":55},[59,60,61],{"name":37,"role":38,"phone":39,"phoneExt":27,"email":40},{"name":42,"role":38,"phone":43,"phoneExt":27,"email":27},{"name":33,"role":34,"phone":27,"phoneExt":27,"email":27},{"type":63,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100634911","health-and-wellness-coaching-to-improve-adherence-to-healthy-habits-and-treatment-plans-in-papillary-and-follicular-thyroid-cancer-survivors-100634911",false,"NCT07545837","Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors","Health and Wellness Coaching to Improve Patient Activation and Adherence to Healthy Habits in Differentiated Thyroid Cancer Care: A Mixed-Methods Pilot Study","Inclusion Criteria:\n\n* Adults ≥ 18 years\n* Histologically confirmed papillary or follicular thyroid carcinoma\n* Status post total thyroidectomy ± radioactive iodine therapy\n* Receiving levothyroxine monotherapy (no triiodothyronine \\[T3\\] or desiccated thyroid products)\n* Thyroid-stimulating hormone (TSH) \\\u003C 4 uIU\u002FmL at ≥ 3 months post-thyroidectomy\n* English proficiency\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Medullary or anaplastic thyroid carcinoma\n* Current systemic therapy for thyroid or other cancers\n* Cognitive or psychiatric impairment precluding participation\n* Inability to complete study procedures","ALL","18 Years",{"count":74,"type":75},20,"ESTIMATED","INTERVENTIONAL",[78],"NA","This clinical trial evaluates the impact of a patient-centered health and wellness coaching (HWC) intervention on adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer. Treatment for thyroid cancer often involves surgery, radioactive iodine and\u002For lifelong levothyroxine with regular monitoring of thyroid stimulating hormone levels. Despite strong survival rates, patients frequently report fatigue, cognitive issues, mood changes, and disruptions in daily life. Treatment burden and psychosocial strain often impair the ability to follow the treatment plan and healthy lifestyle. Studies have shown that HWC motivates patients to take ownership and accountability to perform positive and healthy behavioral changes. HWC may have a positive impact on health-related goal-setting processes and improve self-care and healthcare outcomes in certain settings. It is not yet known how HWC impacts thyroid cancer patients. Incorporating HWC into survivorship care may improve adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer.",[81,82],"Thyroid Gland Follicular Carcinoma","Thyroid Gland Papillary Carcinoma","NOT_YET_RECRUITING","2026-04-22",{"date":86,"type":87},"2026-04-27","ACTUAL",{"date":89,"type":75},"2026-05-26",{"date":91,"type":75},"2027-04-30",{"name":5,"class":6},1]